Purchase Order N0017324P0359
Award Date
9/19/24
Potential Completion Date
10/31/24
Potential Value
$51K
Federal Agency
Office of Naval Research
Ultimate Awardee
Not listed
NAICS Category
325199 - All Other Basic Organic Chemical Manufacturing
PSC Category
6810 - Chemicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Washington, DC 20375, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, is for the purchase of PART NUMBER FLO-MIN114 for $12,358.00. The contract is a Firm Fixed Price purchase order awarded by the Naval Sea Systems Command (NAVSEA), a defense agency. The contract has no set-aside designation and has an ultimate completion date of October 18, 2024. Oxford Nanopore Technologies specializes in nanopore-based electronic systems for analyzing single...
This federal contract award to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company, is for the provision of nanopore flow-cells and a ligation kit. The $19,227.99 firm fixed-price purchase order was awarded by the Northeast Area division of the U.S. Department of Agriculture's Agricultural Research Service. The contract has an ultimate completion date of May 10, 2024. Oxford Nanopore has secured multiple federal contracts and Indefinite Delivery Vehicles (IDVs)...
Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, was awarded a $8,000.00 firm fixed price purchase order by the Department of the Navy Bureau of Medicine and Surgery for MINION Rapid Starter Training and Travel, with a completion date of July 30, 2023. This award has no set-aside designation. Oxford Nanopore Technologies is a prime contractor that has secured numerous federal contract awards, primarily to provide next-generation genomic sequencing...
This federal contract award to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company, provides a software license and device warranty for two GridION instruments to support the Food and Drug Administration's (FDA) next-generation sequencing efforts. The $25,000.00 firm-fixed-price purchase order has a period of performance through September 27, 2025. Oxford Nanopore Technologies is a provider of innovative nanopore-based sequencing platforms, which have been...
The U.S. Defense agency, the Bureau of Medicine and Surgery, awarded a $80,045.00 firm-fixed-price purchase order contract to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract, identified as N3239824P0044, is for the delivery of P2 INTEGRATED CAPEX and has an ultimate completion date of September 29, 2025. Oxford Nanopore Technologies provides next-generation genomic sequencing equipment, consumables, and associated services to various U.S....
This federal contract award was issued by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The $16,500 firm-fixed-price purchase order is for the delivery of Oxford Nanopore's next-generation genomic sequencing equipment, consumables, reagents, software licenses, and associated services. The contract does not have a set-aside designation. Oxford Nanopore Technologies Inc....
This federal contract award, valued at $17,732.00, was made by the United States Department of Agriculture (USDA) Agricultural Research Service (ARS) to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The award is for the provision of various Oxford Nanopore sequencing products, including MinION flow cells, VolTRAX sequencing kits, Flongle flow kits, and flow cell wash kits. These products are to be used with the Oxford Nanopore MinION sequencing device...
This is a firm fixed price purchase order awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Oxford Nanopore Technologies Inc., a foreign-owned for-profit organization, for $21,588.00 in equipment. The contract has no set-aside designation. Oxford Nanopore Technologies Inc. is a biotechnology company that develops nanopore-based electronic systems for analyzing single molecules, including DNA, RNA, and proteins. The company has...
This federal contract award to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, was made by the National Institute for Minority Health and Health Disparities, a civilian agency. The $16,500.00 firm fixed-price purchase order is for the delivery of OXFORD NANOPORE TECHNOLOGIES, INC.; FLOW CELL R9 4.1 products by December 31, 2023. This contract does not have a set-aside designation. Oxford Nanopore Technologies Inc. is a provider of next-generation genomic...
This is a $95,435 firm-fixed-price purchase order (contract) awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency within the Department of Health and Human Services, to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for the supply of NANOPORE - GRIDION, a next-generation genomic sequencing platform. There is no set-aside designation associated with this award. Oxford Nanopore Technologies Inc. has...